Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for
Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for Chemonaïve Patients with Malignant Pleural Mesothelioma: Results of the International Expanded Access Program Armando Santoro, MD, Mary E. O'Brien, MD, Rolf A. Stahel, MD, Kristiaan Nackaerts, MD, Ph. D, Paul Baas, MD, Ph. D, Meinolf Karthaus, MD, Wilfried Eberhardt, MD, Luis Paz-Ares, MD, Ph. D, Stein Sundstrom, MD, Ph. D, Yushan Liu, Ph. D, Veronique Ripoche, Ph. D, Johannes Blatter, MD, Carla M. Visseren-Grul, MD, Christian Manegold, MD Journal of Thoracic Oncology Volume 3 Issue 7 Pages 756 -763 (July 2008) DOI: 10. 1097/JTO. 0 b 013 e 31817 c 73 d 6 Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 1 Journal of Thoracic Oncology 2008 3756 -763 DOI: (10. 1097/JTO. 0 b 013 e 31817 c 73 d 6) Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 2 Journal of Thoracic Oncology 2008 3756 -763 DOI: (10. 1097/JTO. 0 b 013 e 31817 c 73 d 6) Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 3 Journal of Thoracic Oncology 2008 3756 -763 DOI: (10. 1097/JTO. 0 b 013 e 31817 c 73 d 6) Copyright © 2008 International Association for the Study of Lung Cancer Terms and Conditions
- Slides: 4